{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:31:13Z","timestamp":1781087473870,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"DOI":"10.7759\/cureus.44110","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T14:50:11Z","timestamp":1692975011000},"source":"Crossref","is-referenced-by-count":3,"title":["Intravenous Administration of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC) for Acute Respiratory Distress Syndrome Due to COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Jesus A","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J","family":"Parcero Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Corral Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo I","family":"Gomez Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ichim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"McGreevy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"5","author":"Madjid M","year":"2020","unstructured":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020, 5:831-840. 10.1001\/jamacardio.2020.1286","journal-title":"JAMA Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395:507-513. 10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen C","year":"2020","unstructured":"Shen C, Wang Z, Zhao F, et al.. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020, 323:1582-1589. 10.1001\/jama.2020.4783","journal-title":"JAMA"},{"key":"ref4","unstructured":"U.S. Food and Drug Administration Approves Gilead\u2019s Antiviral Veklury\u00ae (remdesivir) for Treatment of COVID-19. (2020). Accessed. October 22, 2020: https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2020\/10\/us-food-and-drug-administration-approves-gile...."},{"key":"ref5","unstructured":"Molnupiravir. first pill to treat Covid gets approval in UK. (2021). Accessed: November 4, 2021: https:\/\/www.bbc.com\/news\/health-59163899."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu C","year":"2020","unstructured":"Wu C, Chen X, Cai Y, et al.. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020, 180:934-943. 10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-481. 10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1490","article-title":"2019 Novel Coronavirus-Important information for clinicians","volume":"323","author":"Del Rio C","year":"2020","unstructured":"Del Rio C, Malani PN. 2019 Novel Coronavirus-Important information for clinicians. JAMA. 2020, 323:1039-1040. 10.1001\/jama.2020.1490","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury","volume":"353","author":"Rubenfeld GD","year":"2005","unstructured":"Rubenfeld GD, Caldwell E, Peabody E, et al.. Incidence and outcomes of acute lung injury. N Engl J Med. 2005, 353:1685-1693. 10.1056\/NEJMoa050333","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu R","year":"2020","unstructured":"Lu R, Zhao X, Li J, et al.. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020, 395:565-574. 10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu X","year":"2020","unstructured":"Xu X, Chen P, Wang J, et al.. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020, 63:457-460. 10.1007\/s11427-020-1637-5","journal-title":"Sci China Life Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming I","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004, 203:631-637. 10.1002\/path.1570","journal-title":"J Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba K","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, et al.. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005, 11:875-879. 10.1038\/nm1267","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100313","article-title":"\"Stemness\" does not explain the repair of many tissues by mesenchymal stem\/multipotent stromal cells (MSCs)","volume":"82","author":"Prockop DJ","year":"2007","unstructured":"Prockop DJ. \"Stemness\" does not explain the repair of many tissues by mesenchymal stem\/multipotent stromal cells (MSCs). Clin Pharmacol Ther. 2007, 82:241-243. 10.1038\/sj.clpt.6100313","journal-title":"Clin Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v12.i10.1067","article-title":"Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome","volume":"12","author":"Lin F","year":"2020","unstructured":"Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. World J Stem Cells. 2020, 12:1067-1079. 10.4252\/wjsc.v12.i10.1067","journal-title":"World J Stem Cells"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/scrt193","article-title":"Therapeutic implications of mesenchymal stem cells in acute lung injury\/acute respiratory distress syndrome","volume":"4","author":"Wang YY","year":"2013","unstructured":"Wang YY, Li XZ, Wang LB. Therapeutic implications of mesenchymal stem cells in acute lung injury\/acute respiratory distress syndrome. Stem Cell Res Ther. 2013, 4:45. 10.1186\/scrt193","journal-title":"Stem Cell Res Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0279","article-title":"Genetic modification of mesenchymal stem cells overexpressing angiotensin II type 2 receptor increases cell migration to injured lung in LPS-induced acute lung injury mice","volume":"7","author":"Xu XP","year":"2018","unstructured":"Xu XP, Huang LL, Hu SL, et al.. Genetic modification of mesenchymal stem cells overexpressing angiotensin II type 2 receptor increases cell migration to injured lung in LPS-induced acute lung injury mice. Stem Cells Transl Med. 2018, 7:721-730. 10.1002\/sctm.17-0279","journal-title":"Stem Cells Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22289","article-title":"Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1\/2-dependent mechanism","volume":"108","author":"Pricola KL","year":"2009","unstructured":"Pricola KL, Kuhn NZ, Haleem-Smith H, Song Y, Tuan RS. Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1\/2-dependent mechanism. J Cell Biochem. 2009, 108:577-588. 10.1002\/jcb.22289","journal-title":"J Cell Biochem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao X","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020, 20:269-270. 10.1038\/s41577-020-0308-3","journal-title":"Nat Rev Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301828","article-title":"IDO-independent suppression of T cell effector function by IFN-\u03b3-licensed human mesenchymal stromal cells","volume":"192","author":"Chinnadurai R","year":"2014","unstructured":"Chinnadurai R, Copland IB, Patel SR, Galipeau J. IDO-independent suppression of T cell effector function by IFN-\u03b3-licensed human mesenchymal stromal cells. J Immunol. 2014, 192:1491-1501. 10.4049\/jimmunol.1301828","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-017-0068-8","article-title":"Hypoxia enhances cell properties of human mesenchymal stem cells","volume":"14","author":"Kwon SY","year":"2017","unstructured":"Kwon SY, Chun SY, Ha YS, et al.. Hypoxia enhances cell properties of human mesenchymal stem cells. Tissue Eng Regen Med. 2017, 14:595-604. 10.1007\/s13770-017-0068-8","journal-title":"Tissue Eng Regen Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01642-6","article-title":"Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats","volume":"11","author":"Ishiuchi N","year":"2020","unstructured":"Ishiuchi N, Nakashima A, Doi S, et al.. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Res Ther. 2020, 11:130. 10.1186\/s13287-020-01642-6","journal-title":"Stem Cell Res Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.12.020","article-title":"Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126","volume":"103","author":"Liu W","year":"2020","unstructured":"Liu W, Li L, Rong Y, et al.. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2020, 103:196-212. 10.1016\/j.actbio.2019.12.020","journal-title":"Acta Biomater"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.07.071","article-title":"Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis","volume":"135","author":"Hu X","year":"2008","unstructured":"Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008, 135:799-808. 10.1016\/j.jtcvs.2007.07.071","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1601-9","article-title":"Comparing atmospheric and hypoxic cultured mesenchymal stem cell transcriptome: implication for stem cell therapies targeting intervertebral discs","volume":"16","author":"Elabd C","year":"2018","unstructured":"Elabd C, Ichim TE, Miller K, Anneling A, Grinstein V, Vargas V, Silva FJ. Comparing atmospheric and hypoxic cultured mesenchymal stem cell transcriptome: implication for stem cell therapies targeting intervertebral discs. J Transl Med. 2018, 16:222. 10.1186\/s12967-018-1601-9","journal-title":"J Transl Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02481-9","article-title":"Extracellular vesicles derived from mesenchymal stromal cells mediate endogenous cell growth and migration via the CXCL5 and CXCL6\/CXCR2 axes and repair menisci","volume":"12","author":"Kawata K","year":"2021","unstructured":"Kawata K, Koga H, Tsuji K, et al.. Extracellular vesicles derived from mesenchymal stromal cells mediate endogenous cell growth and migration via the CXCL5 and CXCL6\/CXCR2 axes and repair menisci. Stem Cell Res Ther. 2021, 12:414. 10.1186\/s13287-021-02481-9","journal-title":"Stem Cell Res Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0146","article-title":"Cell-based therapy to reduce mortality from COVID-19: systematic review and meta-analysis of human studies on acute respiratory distress syndrome","volume":"9","author":"Qu W","year":"2020","unstructured":"Qu W, Wang Z, Hare JM, et al.. Cell-based therapy to reduce mortality from COVID-19: systematic review and meta-analysis of human studies on acute respiratory distress syndrome. Stem Cells Transl Med. 2020, 9:1007-1022. 10.1002\/sctm.20-0146","journal-title":"Stem Cells Transl Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni G","year":"2021","unstructured":"Lanzoni G, Linetsky E, Correa D, et al.. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial. Stem Cells Transl Med. 2021, 10:660-673. 10.1002\/sctm.20-0472","journal-title":"Stem Cells Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00573-y","article-title":"Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms","volume":"31","author":"Zhu R","year":"2021","unstructured":"Zhu R, Yan T, Feng Y, et al.. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. Cell Res. 2021, 31:1244-1262. 10.1038\/s41422-021-00573-y","journal-title":"Cell Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123131-intravenous-administration-of-umbilical-cord-derived-mesenchymal-stem-cells-uc-msc-for-acute-respiratory-distress-syndrome-due-to-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:35Z","timestamp":1707508655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123131-intravenous-administration-of-umbilical-cord-derived-mesenchymal-stem-cells-uc-msc-for-acute-respiratory-distress-syndrome-due-to-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.44110","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}